Skip to Main Content

Author Details

Laura Smeaton
Harvard TH Chan School of Public Health
1996
75
30
PMIDPaper TitleJournal TitlePublished Year
36641094Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens.Contraception2023
37306344Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosis.Pharmacogenet Genomics2023
36694361Perspectives on Adherence From the ACTG 5360 MINMON Trial: A Minimum Monitoring Approach With 12 Weeks of Sofosbuvir/Velpatasvir in Chronic Hepatitis C Treatment.Clin Infect Dis2023
35026142A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial.Lancet Gastroenterol Hepatol2022
35351531Prolonged Cotrimoxazole Prophylaxis Has No Impact on Child Growth in the First Two Years of Life: Findings from a Randomized Controlled Trial in Botswana.J Pediatr2022
35257600Incorporating estimands into clinical trial statistical analysis plans.Clin Trials2022
33870433The Association Between Weight Gain, Sex, and Immune Activation Following the Initiation of Antiretroviral Therapy.J Infect Dis2021
31135883Long-term Outcomes in a Large Randomized Trial of HIV-1 Salvage Therapy: 96-Week Results of AIDS Clinical Trials Group A5241 (OPTIONS).J Infect Dis2020
32645160Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum.J Infect Dis2020
32645159Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial.J Infect Dis2020
32406487Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation.J Infect Dis2020
31563942Screening and Enrollment by Sex in Human Immunodeficiency Virus Clinical Trials in the United States.Clin Infect Dis2020
31021991Low Rate of Sex-specific Analyses in Presentations at the Conference on Retroviruses and Opportunistic Infections (CROI) Meeting, 2018: Room to Improve.J Acquir Immune Defic Syndr2019
29381662Association between HIV status and psychological symptoms in perimenopausal women.Menopause2018
29475784Age Differences by Sex in Antiretroviral-Naïve Participants: Pooled Analysis from Randomized Clinical Trials.J Assoc Nurses AIDS Care2018
29608129HIV-Infected Women Gain More Weight than HIV-Infected Men Following the Initiation of Antiretroviral Therapy.J Womens Health (Larchmt)2018
28277924Follow YOUR Heart: development of an evidence-based campaign empowering older women with HIV to participate in a large-scale cardiovascular disease prevention trial.HIV Clin Trials2017
26892777Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342).J Antimicrob Chemother2016
27472067Predictors of late virologic failure after initial successful suppression of HIV replication on efavirenz-based antiretroviral therapy.HIV Clin Trials2016
27347650Characteristics associated with virologic failure in high-risk HIV-positive participants with prior failure: a post hoc analysis of ACTG 5251.HIV Clin Trials2016
26962236Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults.J Infect Dis2016
26684818In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana.AIDS2016
25681380Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial.Clin Infect Dis2015
26595748HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled Trial.Ann Intern Med2015
26213694A Randomized Comparison of Anthropomorphic Changes With Preferred and Alternative Efavirenz-Based Antiretroviral Regimens in Diverse Multinational Settings.Open Forum Infect Dis2015
26212575Regimen selection in the OPTIONS trial of HIV salvage therapy: drug resistance, prior therapy, and race-ethnicity determine the degree of regimen complexity.HIV Clin Trials2015
26053030Presence of Plasmodium falciparum DNA in Plasma Does Not Predict Clinical Malaria in an HIV-1 Infected Population.PLoS One2015
26035319Comparison of HBV-active HAART regimens in an HIV-HBV multinational cohort: outcomes through 144 weeks.AIDS2015
26017661Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case-Cohort Study.J Acquir Immune Defic Syndr2015
25979186Differences in antiretroviral safety and efficacy by sex in a multinational randomized clinical trial.HIV Clin Trials2015
24657960Immune activation markers in peripartum women in Botswana: association with feeding strategy and maternal morbidity.PLoS One2014
25433664Renal and metabolic toxicities following initiation of HIV-1 treatment regimen in a diverse, multinational setting: a focused safety analysis of ACTG PEARLS (A5175).HIV Clin Trials2014
25037041Vitamin D insufficiency in HIV-infected pregnant women receiving antiretroviral therapy is not associated with morbidity, mortality or growth impairment in their uninfected infants in Botswana.Pediatr Infect Dis J2014
25153084Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial.PLoS One2014
2479960225-Hydroxyvitamin D insufficiency and deficiency is associated with HIV disease progression and virological failure post-antiretroviral therapy initiation in diverse multinational settings.J Infect Dis2014
24759064Combination antiretroviral treatment for women previously treated only in pregnancy: week 24 results of AIDS clinical trials group protocol a5227.J Acquir Immune Defic Syndr2014
24391801Outcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease.PLoS One2013
21437725Acceptability of male circumcision among adolescent boys and their parents, Botswana.AIDS Behav2012
22936892Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings.PLoS Med2012
22687498Operationalizing early antiretroviral therapy in HIV-infected in-patients with opportunistic infections including tuberculosis.Int J Tuberc Lung Dis2012
22870212Detection of microbial translocation in HIV and SIV infection using the Limulus amebocyte lysate assay is masked by serum and plasma.PLoS One2012
21901486Infant feeding practices were not associated with breast milk HIV-1 RNA levels in a randomized clinical trial in Botswana.AIDS Behav2012
21499794Quality of life among individuals with HIV starting antiretroviral therapy in diverse resource-limited areas of the world.AIDS Behav2012
21124227Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana.J Acquir Immune Defic Syndr2011
22024521Sex-associated differences in pre-antiretroviral therapy plasma HIV-1 RNA in diverse areas of the world vary by CD4(+) T-cell count.Antivir Ther2011
21346588Prevalence and clinical associations of CXCR4-using HIV-1 among treatment-naive subtype C-infected women in Botswana.J Acquir Immune Defic Syndr2011
20550776Low uptake of antiretroviral therapy after admission with human immunodeficiency virus and tuberculosis in KwaZulu-Natal, South Africa.Int J Tuberc Lung Dis2010
20961784Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas.Int J Infect Dis2010
19090775Risk factors for early and late transmission of HIV via breast-feeding among infants born to HIV-infected women in a randomized clinical trial in Botswana.J Infect Dis2009
19779705Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors.Eur J Clin Pharmacol2009
  • 1 - 50 of 75

Recommended Authors

Yale School of Medicine, Yale University
Career Start Year 2014
Number of shared co-authors 0
Department of Epidemiology and Johns Hopkins Bloomberg School of Public Health
Career Start Year 2009
Number of shared co-authors 5
School of Public Health, Brown University
Career Start Year 2007
Number of shared co-authors 2
University of California san francisco
Career Start Year 2002
Number of shared co-authors 3
Kaiser Permanente Northern California
Career Start Year 2001
Number of shared co-authors 5
University of California San Diego
Career Start Year 2001
Number of shared co-authors 8
McMaster University
Career Start Year 2001
Number of shared co-authors 1
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2000
Number of shared co-authors 6
Northwestern University Feinberg School of Medicine
Career Start Year 2000
Number of shared co-authors 1
Lausanne University Hospital, University of Lausanne
Career Start Year 1999
Number of shared co-authors 1
Kaiser Permanente Bernard J. Tyson School of Medicine
Career Start Year 1998
Number of shared co-authors 4
&quotMagna Graecia&quot University
Career Start Year 1998
Number of shared co-authors 2
The University of North Carolina School of Medicine
Career Start Year 1997
Number of shared co-authors 8
Department of Medicine Johns Hopkins Medicine. Baltimore MD 21205USA.
Career Start Year 1996
Number of shared co-authors 4
Massachusetts General Hospital
Career Start Year 1996
Number of shared co-authors 5
University Hospital of Modena Policlinico, University of Modena and Reggio Emilia
Career Start Year 1995
Number of shared co-authors 3
Kaiser Permanente San Francisco Medical Center
Career Start Year 1994
Number of shared co-authors 2
Johns Hopkins Bloomberg School of Public Health
Career Start Year 1993
Number of shared co-authors 7
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Career Start Year 1993
Number of shared co-authors 6
university of california los angeles Center for Clinical AIDS Research & Education
Career Start Year 1992
Number of shared co-authors 7
Hospital Germans Trias i Pujol
Career Start Year 1992
Number of shared co-authors 3
Johns Hopkins School of Medicine, Johns Hopkins University
Career Start Year 1990
Number of shared co-authors 10
Harvard School of Public Health
Career Start Year 1989
Number of shared co-authors 11
University of California san francisco
Career Start Year 1988
Number of shared co-authors 11
La Paz University Hospital
Career Start Year 1988
Number of shared co-authors 3
Sacramento Medical Center, Kaiser Permanente Northern California
Career Start Year 1988
Number of shared co-authors 2
University of Nebraska Medical Center
Career Start Year 1987
Number of shared co-authors 8
University of California San Francisco
Career Start Year 1981
Number of shared co-authors 5
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Career Start Year 1979
Number of shared co-authors 5
University of Miami, Miller School of Medicine
Career Start Year 1977
Number of shared co-authors 4

Collaborators

David Geffen School of Medicine, University of California los angeles
Co-authored papers 8
Co-authored papers 8
Co-authored papers 7
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 5
Co-authored papers 5
Vanderbilt University Medical Center
Co-authored papers 5
Center for AIDS Research, University of California San Diego
Co-authored papers 5
Co-authored papers 4
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 3
University of Nebraska Medical Center
Co-authored papers 3
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 3
Johns Hopkins University School of Medicine
Co-authored papers 3
University of Cincinnati
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Duke Clinical Research Institute, Duke University
Co-authored papers 3
Washington University School of Medicine
Co-authored papers 2
Co-authored papers 2
University of Washington
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
University of California
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Northwestern University Feinberg School of Medicine
Co-authored papers 1
Case Western Reserve University
Co-authored papers 1
Co-authored papers 1
Brigham and Women's Hospital
Co-authored papers 1
University of Alabama at Birmingham
Co-authored papers 1
Brown University Center for Biomedical Informatics
Co-authored papers 1
Co-authored papers 1